In recent trading session, Aspire Biopharma Holdings Inc (NASDAQ:ASBP) saw 13.3 million shares changing hands at last check today with its beta currently measuring 0.78. Company’s recent per share price level of $0.57 trading at -$0.17 or -23.39% at last check today assigns it a market valuation of $26.08M. That most recent trading price of ASBP’s stock is at a discount of -2671.93% from its 52-week high price of $15.80 and is indicating a discount of -15.79% from its 52-week low price of $0.66. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.37 million shares which gives us an average trading volume of 192.41K if we extend that period to 3-months.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information

Upright in the red during last session for losing -23.39%, in the last five days ASBP remained trading in the red while hitting it’s week-highest on Friday, 03/07/25 when the stock touched $0.57 price level, adding 37.5% to its value on the day. Aspire Biopharma Holdings Inc’s shares saw a change of -95.07% in year-to-date performance and have moved -34.08% in past 5-day. Aspire Biopharma Holdings Inc (NASDAQ:ASBP) showed a performance of -95.52% in past 30-days. Number of shares sold short was 47452.0 shares which calculate 0.09 days to cover the short interests.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders

Insiders are in possession of 26.24% of company’s total shares while institution are holding 1.03 percent of that, with stock having share float percentage of 1.39%. Investors also watch the number of corporate investors in a company very closely, which is 1.03% institutions for Aspire Biopharma Holdings Inc that are currently holding shares of the company.

On the other hand, Fidelity NASDAQ Composite Index Fund and Tidal ETF Tr-Robinson Alternative Yield Pre-Merger SPAC ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 5.29 shares of worth $3013.0 or 0.07% of the total outstanding shares. The later fund manager was in possession of 3.07 shares on Oct 31, 2024 , making its stake of worth around $1751.0 in the company or a holder of 0.04% of company’s stock.